Listen: Mark Lacy, CEO of Benchmark Research talks about covid vaccine trials taking place in Sacramento and how you can participate.
Johnson & Johnson announced that late-stage study results showed their COVID-19 vaccine candidate to be overall 66% effective and noted that it is considered a strong vaccine by scientists.
Benchmark Research, a trusted national leader in the clinical research industry, is conducting clinical trials of the Johnson & Johnson vaccine at its Sacramento research site.
If you want to participate in the covid vaccine trial:
https://www.benchmarkresearch.net/?gclid=EAIaIQobChMIl5vkr_PT7gIVkxmtBh0o2QYPEAAYASAAEgK1A_D_BwE
,quality(10),blur(50))